LVCLF - Living Cell Technologies Limited

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
3.168
-
-
3.168
9.769
Gross profit
3.168
-
-
3.168
9.769
Operating expenses
Research development
1,788
1,463
1,609
2,384
3,329
Selling general and administrative
1,707
-
-
-
-
Total operating expenses
2,567
2,377
2,284
3,166
4,172
Operating income or loss
-2,567
-2,377
-2,284
-3,163
-4,162
Total other income/expenses net
-10.393
0.619
365.793
1,745
509.257
Income before tax
-2,566
-2,372
-1,905
-1,345
-3,478
Income tax expense
-35.719
-414.729
-444.86
-376.923
-296.154
Income from continuing operations
-2,530
-1,957
-1,461
-968.469
-3,181
Net income
-2,530
-1,957
-1,461
-968.469
-3,181
Net income available to common shareholders
-2,530
-1,957
-1,461
-968.469
-3,181
Basic EPS
-
-0.00
-0.00
-0.00
-0.01
Diluted EPS
-
-0.00
-0.00
-0.00
-0.01
Basic average shares
-
886,621
605,495
605,495
605,495
Diluted average shares
-
886,621
605,495
605,495
605,495
EBITDA
-
-2,376
-2,279
-3,146
-4,110